Self Regional Healthcare

Self Regional Healthcare
1325 Spring Street
Greenwood, SC 29646
864-725-4111

Contact
Lydia Moats, RN, Research Coordinator: lydia.moats@selfregional.org

National Cancer Institute Community Oncology Research Program logo

As an affiliate of the Medical University of South Carolina, Self Regional Healthcare is an active Minority/Underserved NCORP site. Self Regional Healthcare is currently active on the following clinical trials addressing various cancer types. Ask your health care provider for more information.

All Disease Sites

  • S1912CD: A Randomized Trial Addressing Cancer-Related Financial Hardship Through Delivery of a Proactive Financial Navigation Intervention (CREDIT)
    This trial examines a financial navigation program in helping patients and their spouses understand and better manage the financial aspects of cancer care.
    Trial Details

Breast

  • CCTG MA.39: Testing regional radiation therapy in patients with low risk breast cancer
    This trial studies if not giving regional radiotherapy is just as good as using regional radiotherapy in keeping breast cancer from coming back in patients with estrogen receptor-positive, HER2-negative, node-positive low-risk breast cancer who have undergone breast conserving surgery or mastectomy.
    Trial Details

Gastrointestinal

  • A221805: Duloxetine to prevent oxaliplatin-induced peripheral neuropathy
    This trial studies the best dose of duloxetine and how well it works in preventing pain, tingling, numbness and muscle weakness (peripheral neuropathy) caused by treatment with oxaliplatin in patients with stage II-III colorectal cancer.
    Trial Details
  • WF-1806: Low Muscle Mass and its Role in Side Effects from Chemotherapy in Older Adults with Colorectal Cancer
    This trial studies if myopenia (low muscle mass) plays a role in experiencing side effects from chemotherapy in older patients with colorectal cancer that has spread to other areas of the body.
    Trial Details

Genitourinary

  • GU005: Testing short course of radiation therapy versus usual radiation therapy for prostate cancer
    This trial studies how well stereotactic body radiation therapy works compared to intensity-modulated radiation therapy in treating patients with stage IIA-B prostate cancer.
    Trial Details
  • GU009: Two studies for patients with high risk prostate cancer testing less intense treatment for patients with a low gene risk score and testing a more intense treatment for patients with a high gene risk score
    This trial compares less intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in treating patients with high risk prostate cancer and low gene risk score.
    Trial Details
  • GU010: Two Studies for Patients with Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients with a Low Gene Risk Score and Testing a More Intense Treatment for Patients with a Higher Gene Risk Score
    This trial uses the Decipher risk score to guide therapy selection. Decipher score is based on the activity of 22 genes in prostate tumor and may predict how likely it is for recurrent prostate cancer to spread (metastasize) to other parts of the body.
    Trial Details

Head & Neck

  • HN009: Comparing High-Dose Cisplatin Every Three Weeks to Low-Dose Cisplatin Weekly When Combined with Radiation for Patients with Advanced Head and Neck Cancer (Pending Activation)
    This trial compares whether low-dose cisplatin given weekly with radiation is better tolerated than high-dose cisplatin given every three weeks with radiation therapy for the treatment of head & neck cancer that has spread to other places in the body.
    Trial Details

Neuro-Oncology

  • CCTG CE.7: A study comparing stereotactic radiosurgery to whole brain radiotherapy (using a technique that avoids the hippocampus) with memantine in people with cancer that has spread to the brain
    This trial studies stereotactic radiosurgery to see how well it works compared to hippocampus avoidance whole-brain radiation therapy with memantine in treating patients with 5-15 brain tumors that have spread from other places in the body.
    Trial Details

Thoracic/Lung

  • CC003: Testing whether avoiding the hippocampus during whole-brain radiation therapy prevents cognitive side effects in patients with small cell lung cancer
    This trial studies whether avoiding the hippocampus during whole-brain radiation therapy prevents cognitive side effects in patients with small cell lung cancer that is found in one lung, the tissues between the lungs, and nearby lymph nodes only (limited stage) or has spread outside of the lung in which it began or to other parts of the body (extensive stage).
    Trial Details
  • CC009: Testing if high dose radiation only to the sites of brain cancer compared to whole brain radiation that avoids the hippocampus is better at preventing loss of memory and thinking ability
    This trial compares the effect of stereotactic radiosurgery to standard of care memantine and whole brain radiation therapy that avoids the hippocampus (the memory zone of the brain) for the treatment of small cell lung cancer that has spread to the brain.
    Trial Details
  • EA5191: Testing the addition of the pill chemotherapy, cabozantinib, to the standard immune therapy nivolumab compared to standard chemotherapy for non-squamous non-small cell lung cancer
    This trial compares cabozantinib alone and the combination of cabozantinib and nivolumab to standard chemotherapy in the treatment of patients with non-squamous non-small cell lung cancer (NSCLC).
    Trial Details
  • LU007: Testing the addition of radiation therapy to the usual immune therapy treatment (atezolizumab) for patients with extensive stage small cell lung cancer
    This trial compares the effect of adding radiation therapy to the usual maintenance therapy with atezolizumab versus atezolizumab alone in patients who have already received atezolizumab plus chemotherapy for the treatment of small cell lung cancer that has spread outside of the lung or to other parts of the body (extensive stage).
    Trial Details